Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment.
Anne-Kristina MercierMikael SunnåkerSebastian UeckertTadeusz PawlikEmilia HenricsonOleksandr MolodetskyiGordon C LawVictoria E R ParkerJan OscarssonPublished in: Clinical pharmacokinetics (2023)
ClinicalTrials.gov identifier: NCT05112419.